Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study

American Heart Journal

Volumn 151, Issue 2, 2006, Pages 492-500

  Astor, Brad C ^a,b   Coresh, Josef ^a,b,c   Heiss, Gerardo ^d   Pettitt, Dan ^e   Sarnak, Mark J ^f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

^e AMGEN INC   (United States)

^f TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANEMIA; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; KIDNEY DYSFUNCTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT;

ANEMIA; CAUSE OF DEATH; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS;

EID: 31344445271     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.03.055     Document Type: Article

References (48)

1. A.S. Levey, J.A. Beto, and B.E. Coronado Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease Am J Kidney Dis 32 1998 853 906
2. J. Coresh, B.C. Astor, and T. Greene Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey Am J Kidney Dis 41 2003 1 12
3. A. Al-Ahmad, W.M. Rand, and G. Manjunath Reduced kidney function and anemia as risk factors for mortality inpatients with left ventricular dysfunction J Am Coll Cardiol 38 2001 955 962
4. R.D. Langston, R. Presley, and W.D. Flanders Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction Kidney Int 64 2003 1398 1405
5. S. Beddhu, K. Allen-Brady, and A.K. Cheung Impact of renal failure on the risk of myocardial infarction and death Kidney Int 62 2002 1776 1783
6. G. Manjunath, H. Tighiouart, and H. Ibrahim Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community J Am Coll Cardiol 41 2003 47 55
7. P. Muntner, J. He, and L. Hamm Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States J Am Soc Nephrol 13 2002 745 753
8. R.M. Henry, P.J. Kostense, and G. Bos Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study Kidney Int 62 2002 1402 1407
9. C.T. Jurkovitz, J.L. Abramson, and L.V. Vaccarino Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based Atherosclerosis Risk in Communities (ARIC) Study J Am Soc Nephrol 14 2003 2919 2925
10. G. Manjunath, H. Tighiouart, and J. Coresh Level of kidney function as a risk factor for cardiovascular outcomes in the elderly Kidney Int 63 2003 1121 1129
11. L.F. Fried, M.G. Shlipak, and C. Crump Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals J Am Coll Cardiol 41 2003 1364 1372
12. B.F. Culleton, M.G. Larson, and P.W. Wilson Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency Kidney Int 56 1999 2214 2219
13. A.X. Garg, W.F. Clark, and R.B. Haynes Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I Kidney Int 61 2002 1486 1494
14. B.C. Astor, P. Muntner, and A. Levin Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 162 2002 1401 1408
15. R.N. Foley, P.S. Parfrey, and G.M. Kent Long-term evolution of cardiomyopathy in dialysis patients Kidney Int 54 1998 1720 1725
16. J.D. Harnett, R.N. Foley, and G.M. Kent Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors Kidney Int 47 1995 884 890
17. R.N. Foley, P.S. Parfrey, and J.D. Harnett The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease Am J Kidney Dis 28 1996 53 61
18. A. Levin, C.R. Thompson, and J. Ethier Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin Am J Kidney Dis 34 1999 125 134
19. C. Rigatto, R. Foley, and J. Jeffery Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia J Am Soc Nephrol 14 2003 462 468
20. J.J. De Lima, M.L. Vieira, and L.F. Viviani Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients Nephrol Dial Transplant 17 2002 645 651
21. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators Am J Epidemiol 129 1989 687 702
22. A.C. Papp, H. Hatzakis, and A. Bracey ARIC hemostasis study-I. Development of a blood collection and processing system suitable for multicenter hemostatic studies Thromb Haemost 61 1989 15 19
23. Operations Manual 7: Blood Collection and Processing. 1987. Bethesda, National Heart, Lung and Blood Institute. National Heart Lung and Blood Institute Atherosclerosis Risk in Communities (ARIC) Study.
24. A. Clauss Gerinnungsphysiologische Schnellmethode zur Bestimmung des fibrinogens Acta Haematol 17 1957 237 246
25. J.H. Eckfeldt, L.E. Chambless, and Y.L. Shen Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study Arch Pathol Lab Med 118 1994 496 500
26. A.S. Levey, T. Greene, and J.W. Kusek A simplified equation to predict glomerular filtration rate from serum creatinine J Am Soc Nephrol 11 2000 155A
27. J. Coresh, B.C. Astor, and G. McQuillan Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate Am J Kidney Dis 39 2002 920 929
28. A.D. White, A.R. Folsom, and L.E. Chambless Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience J Clin Epidemiol 49 1996 223 233
29. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation. Kidney disease outcome quality initiative Am J Kidney Dis 39 2002 S1 S246
30. StataCorp mkspline-Linear spline construction, Stata statistical software: release 6.0 1999 Stata Corporation College Station (Tex) 374 376
31. StataCorp Stata statistical software: release 6.0 1999 Stata Corporation College Station (Tex)
32. M.G. Shlipak, P.A. Heidenreich, and H. Noguchi Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients Ann Intern Med 137 2002 555 562
33. J.F. Mann, H.C. Gerstein, and J. Pogue Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629 636
34. J. Coresh, J.C. Longenecker, and E.R.I. Miller Epidemiology of cardiovascular risk factors in chronic renal disease J Am Soc Nephrol 9 1998 S24 S30
35. G. Leoncini, F. Viazzi, and D. Parodi Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension Hypertension 42 2003 14 18
36. M.J. Sarnak, and A.S. Levey Cardiovascular disease and chronic renal disease: a new paradigm Am J Kidney Dis 35 2000 S117 S131
37. P. Muntner, L.L. Hamm, and J.W. Kusek The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease Ann Intern Med 140 2004 9 17
38. M.J. Sarnak, H. Tighiouart, and G. Manjunath Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) Study J Am Coll Cardiol 40 2002 27 33
39. F. Metivier, S.J. Marchais, and A.P. Guerin Pathophysiology of anaemia: focus on the heart and blood vessels [in process citation] Nephrol Dial Transplant 15 Suppl 3 2000 14 18
40. R.N. Foley, P.S. Parfrey, and J. Morgan Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy Kidney Int 58 2000 1325 1335
41. G.F. Strippoli, J.C. Craig, and C. Manno Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials J Am Soc Nephrol 15 2004 3154 3165
42. J. Portoles, A. Torralbo, and P. Martin Cardiovascular effects of recombinant human erythropoietin in predialysis patients Am J Kidney Dis 29 1997 541 548
43. T. Hayashi, A. Suzuki, and T. Shoji Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure Am J Kidney Dis 35 2000 250 256
44. S.D. Roger, L.P. McMahon, and A. Clarkson Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial J Am Soc Nephrol 15 2004 148 156
45. K.U. Eckardt The CREATE trial-building the evidence Nephrol Dial Transplant 16 Suppl 2 2001 16 18
46. M. Rao, and B.J. Pereira Prospective trials on anemia of chronic disease: the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Kidney Int Suppl 2003 S12 S19
47. J.L. Abramson, C.T. Jurkovitz, and V. Vaccarino Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study Kidney Int 64 2003 610 615
48. M. Annuk, L. Lind, and T. Linde Impaired endothelium-dependent vasodilatation in renal failure in humans Nephrol Dial Transplant 16 2001 302 306